Minocycline
Minocycline.JPG

CLINICAL USE

Antibacterial agent

DOSE IN NORMAL RENAL FUNCTION

100 mg twice dailyAcne: 100 mg daily in 1 or 2 divided doses

PHARMACOKINETICS

  • Molecular weight                           :457.5
  • %Protein binding                           :75
  • %Excreted unchanged in urine     : 5–10
  • Volume of distribution (L/kg)       :1–1.5
  • half-life – normal/ESRD (hrs)      :11–26/12–18

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. Dose as in normal renal function
  • HD                     :Not dialysed. Dose as in normal renal function
  • HDF/high flux   :Unknown dialysability. Dose as in normal renal function
  • CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Anticoagulants: possibly enhanced anticoagulant effect of coumarins and phenindione
  • Oestrogens: possibly reduced contraceptive effect of oestrogens (risk probably small)
  • Retinoids: possibly increased risk of benign intracranial hypertension – avoid concomitant use

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    Do not take iron preparations, indigestion remedies or phosphate binders at the same time of day as minocycline.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs